← Eichor
Study identifier: NCT02956031 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.

Condition: Cervical Cancer · High Grade Sil · CIN2  ·  Sponsor: University of Pretoria

PhaseN/A
Planned participants1500
Who can joinFemale, 25 Years to 75 Years
Healthy volunteersYes

About this study

Nearly 8 000 new cervical cancer cases are diagnosed in South Africa per year; many are still undiagnosed and about 50% of diagnosed cases succumb per year. Although the current prevalence of pre-cancer cervical disease is largely unknown, data from local studies suggest regional differences and an increase in the prevalence of cytological abnormalities when compared with historical data. Low frequency in cytology screening is the primary factor attributable to development of invasive cervical cancer and almost one-third of all cervical cancer patients had previous negative cytology. Due to the low sensitivity of cytology it can be assumed that the true prevalence of pre-cancer disease is underestimated by all available data. One round of optimal cervical cytology will detect around 50% of existing pre-cancer cervical disease as identified and proven using colposcopy and directed biopsy. It is now widely accepted that primary screening with a human papilloma virus (HPV) test can improve the sensitivity of screening and that even a single round of HPV screening can rapidly reduce the incidence of invasive cervical cancer and related mortality within a few years. South Africa has a high prevalence of HIV infection and a delay in or failure to initiate antiretroviral therapy (ART). These facts, together with the largely unscreened status of the female population and the high incidence of cervical cancer all suggest that HPV infection and precursors to cervical cancer are both u…

This description comes directly from the study's public registry record.

Talk to the study team

Greta Dreyer, PhD  ·  +(27) 12 354 3900  ·  greta.dreyer@up.ac.za

Cathy Visser, MSc  ·  +(27) 12 354 3900  ·  cathy.visser@up.ac.za

Always discuss trial participation with your own doctor first.

Locations (1)

Steve Biko Academic HospitalPretoria, Gauteng, South AfricaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02956031